PURPOSE: To determine the effectiveness of MR angiography for pulmonary embolism (MRA-PE) in symptomatic patients. MATERIALS AND METHODS: We retrospectively reviewed all patients whom were evaluated for possible pulmonary embolism (PE) using MRA-PE. A 3-month and 1-year from MRA-PE electronic medical record (EMR) review was performed. Evidence for venous thromboembolism (VTE) (or death from PE) within the year of follow-up was the outcome surrogate for this study. RESULTS: There were 190 MRA-PE exams performed with 97.4% (185/190) of diagnostic quality. There were 148 patients (120 F: 28 M) that had both a diagnostic MRA-PE exam and 1 complete year of EMR follow-up. There were 167 patients (137 F: 30 M) with 3 months or greater follow-up. We found 83% (139/167) and 81% (120/148) MRA-PE exams negative for PE at 3 months and 1 year, respectively. Positive exams for PE were seen in 14% (23/167). During the 1-year follow-up period, five patients (false negative) were diagnosed with DVT (5/148 = 3.4 %), and one of these patients also experienced a non-life-threatening PE. The negative predictive value (NPV) for MRA-PE was 97% (92-99; 95% CI) at 3 months and 96% (90-98; 95% CI) with 1 year of follow-up. CONCLUSION: The NPV of MRA-PE, when used for the primary diagnosis of pulmonary embolism in symptomatic patients, were found to be similar to the published values for CTA-PE. In addition, the technical success rate and safety of MRA-PE were excellent.
PURPOSE: To determine the effectiveness of MR angiography for pulmonary embolism (MRA-PE) in symptomatic patients. MATERIALS AND METHODS: We retrospectively reviewed all patients whom were evaluated for possible pulmonary embolism (PE) using MRA-PE. A 3-month and 1-year from MRA-PE electronic medical record (EMR) review was performed. Evidence for venous thromboembolism (VTE) (or death from PE) within the year of follow-up was the outcome surrogate for this study. RESULTS: There were 190 MRA-PE exams performed with 97.4% (185/190) of diagnostic quality. There were 148 patients (120 F: 28 M) that had both a diagnostic MRA-PE exam and 1 complete year of EMR follow-up. There were 167 patients (137 F: 30 M) with 3 months or greater follow-up. We found 83% (139/167) and 81% (120/148) MRA-PE exams negative for PE at 3 months and 1 year, respectively. Positive exams for PE were seen in 14% (23/167). During the 1-year follow-up period, five patients (false negative) were diagnosed with DVT (5/148 = 3.4 %), and one of these patients also experienced a non-life-threatening PE. The negative predictive value (NPV) for MRA-PE was 97% (92-99; 95% CI) at 3 months and 96% (90-98; 95% CI) with 1 year of follow-up. CONCLUSION: The NPV of MRA-PE, when used for the primary diagnosis of pulmonary embolism in symptomatic patients, were found to be similar to the published values for CTA-PE. In addition, the technical success rate and safety of MRA-PE were excellent.
Authors: A Perrier; N Howarth; D Didier; P Loubeyre; P F Unger; P de Moerloose; D Slosman; A Junod; H Bounameaux Journal: Ann Intern Med Date: 2001-07-17 Impact factor: 25.391
Authors: M P Revel; O Sanchez; S Couchon; B Planquette; A Hernigou; R Niarra; G Meyer; G Chatellier Journal: J Thromb Haemost Date: 2012-05 Impact factor: 5.824
Authors: A Gupta; C K Frazer; J M Ferguson; A B Kumar; S J Davis; M J Fallon; I T Morris; P J Drury; L A Cala Journal: Radiology Date: 1999-02 Impact factor: 11.105
Authors: Anouk Pijpe; Nadine Andrieu; Douglas F Easton; Ausrele Kesminiene; Elisabeth Cardis; Catherine Noguès; Marion Gauthier-Villars; Christine Lasset; Jean-Pierre Fricker; Susan Peock; Debra Frost; D Gareth Evans; Rosalind A Eeles; Joan Paterson; Peggy Manders; Christi J van Asperen; Margreet G E M Ausems; Hanne Meijers-Heijboer; Isabelle Thierry-Chef; Michael Hauptmann; David Goldgar; Matti A Rookus; Flora E van Leeuwen Journal: BMJ Date: 2012-09-06
Authors: Peter J Bergquist; Michael S Chung; Anja Jones; Mark A Ahlman; Charles S White; Jean Jeudy Journal: Curr Cardiol Rep Date: 2017-05 Impact factor: 2.931
Authors: Donald G Benson; Mark L Schiebler; Michael D Repplinger; Christopher J François; Thomas M Grist; Scott B Reeder; Scott K Nagle Journal: Br J Radiol Date: 2017-04-12 Impact factor: 3.039
Authors: Peter Bannas; Mark L Schiebler; Utaroh Motosugi; Christopher J François; Scott B Reeder; Scott K Nagle Journal: Eur Radiol Date: 2014-05-28 Impact factor: 5.315
Authors: Michael D Hope; Thomas A Hope; Chengcheng Zhu; Farshid Faraji; Henrik Haraldsson; Karen G Ordovas; David Saloner Journal: AJR Am J Roentgenol Date: 2015-06-23 Impact factor: 3.959
Authors: Peter Bannas; Laura C Bell; Kevin M Johnson; Mark L Schiebler; Christopher J François; Utaroh Motosugi; Daniel Consigny; Scott B Reeder; Scott K Nagle Journal: Radiology Date: 2015-09-30 Impact factor: 11.105
Authors: Scott K Nagle; Mark L Schiebler; Michael D Repplinger; Christopher J François; Karl K Vigen; Rajkumar Yarlagadda; Thomas M Grist; Scott B Reeder Journal: Eur J Radiol Date: 2015-12-29 Impact factor: 3.528
Authors: Michael D Repplinger; Rebecca L Bracken; Brian W Patterson; Manish N Shah; Michael S Pulia; John B Harringa; Mark L Schiebler; Scott K Nagle Journal: J Am Coll Radiol Date: 2018-04-30 Impact factor: 5.532